Anna G. Phillips

Anna G. Phillips is a director in the Trial & Appellate Practice Group at Sterne, Kessler, Goldstein & Fox, where she handles complex patent matters in federal courts, at the U.S. International Trade Commission (ITC), and before the Patent Trial and Appeal Board (PTAB). Her litigation experience covers a broad range of technologies, including pharmaceuticals (Hatch-Waxman), biologics, medical devices, robotics, electronics, and consumer products. Prior to joining Sterne Kessler, she was a patent litigation associate at Wilson Sonsini Goodrich & Rosati and served as a law clerk at the U.S. Court of Appeals for the Federal Circuit for the Honorable Jimmie V. Reyna and at the U.S. District Court for the Eastern District of Texas.

The provided data shows one appearance on behalf of a plaintiff, but Phillips's broader practice includes representing both patent holders and accused infringers. Her notable plaintiff-side work includes representing TwinStrand and the University of Washington in a case that resulted in an $83.4 million jury verdict against Guardant Health for willful infringement. On the defense side, she has secured a judgment of no induced infringement for Teva Pharmaceuticals in a Hatch-Waxman litigation and a summary judgment of invalidity for Sweegen that was affirmed on appeal by the Federal Circuit. The tracked case, Biocon Biologics, Inc. v. Regeneron Pharmaceuticals, Inc., involves patent litigation over a biosimilar drug.

Phillips has an active practice before the PTAB and frequently writes and presents on developments at the Federal Circuit. Her representative matters also include leading ITC investigations.

She received her J.D., cum laude, from the University of San Diego School of Law and holds a B.S. in Architectural Engineering and a B.A. from The University of Texas at Austin.